Evidence map›Paper›PMID 38005835›Full record

ArticleViruses2023

A Distinct Anti-EBV DNase Profile in Patients with Undifferentiated Nasopharyngeal Carcinoma Compared to Classical Antigens.

Hamid Melouli, Abdelhalim Khenchouche, Fouzia Taibi-Zidouni, Dahmani Salma, Nassim Aoudia, Djamel Djennaoui, Tewfik Sahraoui, Samir Benyahia, Fatima Zohra El Kebir

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Hamid MelouliViral Oncogenesis Laboratory, Pasteur Institute of Algeria, Algiers 16000, Algeria.
Abdelhalim KhenchoucheLaboratory of Applied Biochemistry, Ferhat Abbas, Setif 1 University, Setif 19000, Algeria.
Fouzia Taibi-ZidouniViral Oncogenesis Laboratory, Pasteur Institute of Algeria, Algiers 16000, Algeria.
Dahmani SalmaViral Oncogenesis Laboratory, Pasteur Institute of Algeria, Algiers 16000, Algeria.
Nassim AoudiaViral Oncogenesis Laboratory, Pasteur Institute of Algeria, Algiers 16000, Algeria.
Djamel DjennaouiOtorhinolaryngology Department, Mustapha Pacha Hospital, Algiers 16000, Algeria.
Tewfik SahraouiLaboratory of Developmental Biology and Differentiation, Es-Sénia University, Oran 31000, Algeria.
Samir BenyahiaOtorhinolaryngology Department, Mustapha Pacha Hospital, Algiers 16000, Algeria.
Fatima Zohra El KebirLaboratory of Developmental Biology and Differentiation, Es-Sénia University, Oran 31000, Algeria.
Institut Pasteur d'Algérie · DZHôpital Mustapha Pacha · DZUniversité Oran 1 Ahmed Ben Bella · DZUniversity Ferhat Abbas of Setif · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasopharyngeal cancer (NPC) is a prevalent type of cancer that often takes the form of undifferentiated carcinoma in the Maghreb region. It affects people of all ages. NPC diagnosis, mainly based on detecting Epstein-Barr virus (EBV), has not been well evaluated in North Africa. We compared the classical EBV serological tests using indirect immunofluorescence to the detection of EBV DNase antibodies by immunoblot in Algerian NPC patients. Significant variations were observed among different age groups of patients regarding the presence of VCA-IgA antibodies (0-14 and ≥30 years old,

Indexed as

Epstein-Barr Virus InfectionsHead and Neck NeoplasmsNasopharyngeal NeoplasmsAdultAgedAntibodies, ViralAntigens, ViralCapsid ProteinsChildDeoxyribonucleasesHerpesvirus 4, HumanHumansImmunoglobulin AImmunoglobulin GNasopharyngeal CarcinomaSquamous Cell Carcinoma of Head and NeckAntibodies, ViralAntigens, ViralCapsid ProteinsDeoxyribonucleasesImmunoglobulin AImmunoglobulin GdiagnosisDNaseEAEBVundifferentiated nasopharyngeal carcinomaVCA

Identifiers

PMID38005835
PMCPMC10675439
OpenAlexW4387971984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.